This study compared intrathecal hyperbaric bupivacaine with low-dose intrathecal plain bupivacaine plus different doses of meperidine (pethidine), administered sequentially, with regard to blood pressure stability, post-operative analgesia and incidence of side-effects in 80 parturients undergoing caesarean section. Patients were randomly assigned to one of four groups (n = 20 each group): the HB group received 10 mg hyperbaric bupivacaine intrathecally; the BM35, BM30 and BM25 groups received 5 mg plain bupivacaine plus 35, 30 or 25 mg of meperidine intrathecally, respectively. The incidence of hypotension in the BM25 group was significantly lower than in the HB group. Nausea and vomiting were less prevalent in the BM25 group than in the HB and BM35 groups. In conclusion, sequential administration of 5 mg plain bupivacaine and 25 mg meperidine intrathecally provided better blood pressure stability and a lower incidence of side-effects than bupivacaine alone, without affecting quality of anaesthesia or surgical and patient satisfaction.
Introduction
Spinal anaesthesia is an effective and safe anaesthetic technique that is frequently used in obstetric procedures. 1 Spinal anaesthesiainduced hypotension is a common problem during caesarean section. The frequency of hypotension during spinal anaesthesia has been reported to range from 30 -100% and it is considered to be the most important sideeffect associated with this type of anaesthesia. 2,3 Many variables affect the spread of spinal anaesthesia, with the dose of local anaesthetic used being the most important influencing factor. 4 A minimal increase in the local anaesthetic dose lowers the incidence of inadequate anaesthesia, although it may also lead to an increase in the incidence of side-effects such as hypotension, bradycardia, nausea and vomiting. 3 The density of cerebrospinal fluid (CSF) at 37°C has been reported to be 1.00021 -1.003 g/ml. 5 Thus, anaesthetists C Atalay, M Aksoy, AN Aksoy et al.
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consider agents with a density lower than 1.00021 g/ml to be hypobaric, and those with a density higher than 1.003 g/ml to be hyperbaric. 5 It is commonly believed that hyperbaric solutions of local anaesthetic agents may provide a more adequate level of surgical anaesthesia than their isobaric (or plain) equivalents. 6 Total sympathetic blockade occurs when local anaesthetics reach a certain density at these levels, resulting in serious hypotension, which thereby poses a risk for both the mother and baby. 6 Researchers attempting to decrease the incidence of haemodynamic instability have reduced the dose of intrathecal bupivacaine by combining it with various opiates to improve the quality of anaesthesia. 6 One paper reported that adding opioids to lowdose (5 -7 mg) local anaesthetic reduced the incidence of hypotension. 7 Even though numerous opioids are used in spinal anaesthesia, meperidine (pethidine) is one of the preferred agents, mainly due to its long duration of action, its good post-operative analgesic effects and its low cost. 8 Meperidine differs from other opioids because it possesses considerable local anaesthetic properties and is hyperbaric. 5 Additionally, neurological dysfunction as a result of intrathecal meperidine use has not been reported in the literature. 9 The most commonly studied dose of intrathecal meperidine is 1 mg/kg. Intrathecal meperidine has, however, a narrow therapeutic window and respiratory depression -and other sideeffects, such as nausea and vomiting, pruritus and urinary retention -can occur with doses as low as 0.5 mg/kg. 10, 11 Cesur et al. 12 stated that the sequential administration of low doses of plain and hyperbaric bupivacaine during spinal anaesthesia reduced the incidence of hypotension, nausea and vomiting. Based on these findings, we proposed that sequential subarachnoid injections of low doses of plain bupivacaine and hyperbaric meperidine could achieve similar results. To identify the most effective dose of meperidine with which to eliminate discomfort with minimal sideeffects, 35, 30 or 25 mg meperidinecorresponding to 0.47, 0.40 and 0.33 mg/kg respectively -were administered intrathecally, in different groups of parturients undergoing elective caesarean sections.
The objectives of the present study were to determine blood pressure stability, patient and surgical comfort, duration of postoperative analgesia and incidence of other side-effects associated with the sequential subarachnoid (intrathecal) administration of low-dose (5 mg) plain bupivacaine and 35, 30 or 25 mg meperidine compared with the standard dose (10 mg) of hyperbaric bupivacaine.
Patients and methods

PATIENT POPULATION
This study included patients who were scheduled to undergo elective caesarean section at the Department of Anaesthesia and Reanimation, Medical Faculty, Atatürk University, Erzurum, Turkey, between June and October 2009. Parturients who were classified as American Society of Anesthesiologists (ASA) physical status I or II 13 were randomly allocated to one of four groups. Inclusion criteria consisted of noncomplicated pregnancies scheduled for elective caesarean section, without contraindications to regional anaesthesia, and patients being taller than 152 cm. Parturients with systemic diseases (e.g. preeclampsia, hepatorenal disease, a bleeding diathesis, etc.), a known fetal anomaly, placenta previa, abruptio placentae, and/or an allergy to any of the study drugs were excluded from the study. C Atalay, M Aksoy, AN Aksoy et al.
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The study protocol was approved by the Ethics Committee of the Department of Anaesthesiology and Reanimation, Faculty of Medicine, Atatürk University, and written informed consent was obtained from all study participants.
SPINAL ANAESTHESIA AND SURGICAL PROCEDURES
All women were monitored by electrocardiogram, non-invasive blood pressure and pulse oximetry. Lactated Ringer's solution (10 ml/kg) was infused over a 20-min period before induction of spinal anaesthesia, and the infusion was continued during surgery. Spinal anaesthesia was performed in the sitting position between the L3 -L4 or L4 -L5 intervertebral spaces. After disinfection, the skin and subcutaneous region were infiltrated with 1% lidocaine and the introducer was inserted through the appropriate intervertebral space. A 25-gauge Quincke spinal needle was inserted through the introducer to access the subarachnoid space. After free flow of CSF was observed, 10 mg of 0.5% (2 ml) hyperbaric bupivacaine (Marcaine Spinal Heavy, 5 ml ampule; Astra Zeneca, Lund, Sweden) was administered intrathecally in the HB group, and 5 mg of 0.5% (1 ml) plain bupivacaine (0.5% Marcaine, 20 ml flacon; Astra Zeneca) was administered intrathecally with either 35 mg (0.70 ml), 30 mg (0.60 ml) or 25 mg (0.50 ml) of meperidine (pethidine) (B Braun Mensulgen AG, Mensulgen, Germany) in the BM35, BM30 and BM25 groups, respectively. Plain bupivacaine was administered first, followed immediately by hyperbaric meperidine.
Intrathecal drugs were administered over a period of 10 s without withdrawal of spinal fluid (barbotage). Afterwards, all women were immediately positioned with a wedge under their right hip to alleviate aortocaval compression. Oxygen was administered at a flow rate of 3 -4 l/min via a face mask until delivery. Patients were stabilized by administering 10 mg ephedrine intravenously (i.v.) when their mean blood pressure decreased by more than 15 -20% from baseline; this dose was repeated if necessary. Surgery was initiated when the sensory block reached at least the T4 dermatome.
A nurse anaesthesist prepared solutions, and the anaesthetist who performed the subarachnoid injection was not subsequently involved in the study. All assessments were made by independent anaesthetists blinded to both the anaesthetic technique and the anaesthetic drug used for each patient.
STUDY MEASUREMENTS
Heart rate, respiratory rate, oxygen saturation and non-invasive blood pressure were recorded every minute for 15 min, then at 5-min intervals for 45 min followed by 30min intervals for another 6 h.
Degree of motor block was recorded every minute for 15 min, then at 15-min intervals for 30 min followed by 30-min intervals until total motor recovery was achieved. The degree of motor block was assessed by the Bromage scale (0, no block; 1, impaired hip flexion; 2, impaired hip and knee movement; and 3, impaired hip, knee and ankle movement). The time to complete motor recovery was determined as the amount of time that elapsed between administration of the subarachnoid injection and achievement of a modified Bromage scale score of 0. The pin-prick test was used to evaluate sensory block. This test was performed with a 24gauge blunted needle bilaterally along the mid-clavicular line at 2-min intervals for the first 15 min after the injection, followed by 15-min intervals for the next 30 min, Intrathecal bupivacaine and meperidine for caesarean section and then at 30-min intervals until sensation was noted at the T10 dermatome (surgical incision level). The pin-prick test was repeated every 20 -30 min, postoperatively. After normal pin-prick sensation had returned and patients had regained their ability to lift their legs normally, they were transferred from the post-anaesthesia care unit (PACU) to the labour and delivery ward.
In the post-operative period, parturients were asked to evaluate their pain according to a 0 -10 visual analogue scale (VAS; 0, no pain; 10, worst pain imaginable). The duration of analgesia was defined as the amount of time that elapsed between the spinal injection and first analgesic requirement. The duration of effective analgesia was defined as the time that elapsed between the spinal injection and the time at which a patient described their pain as ≥ 3 on the VAS. If a patient's VAS was > 3, 0.5 µg/kg fentanyl i.v. was administered. Abdominal muscle relaxation was assessed clinically as poor, fair or good by the surgeons, who were blinded to the intrathecal anaesthetic drugs used. Patients were asked to score their comfort as poor, fair, good or excellent, both during surgery and immediately after arrival in the PACU. In addition, the patients were observed for the presence of nausea, vomiting, pruritus and other side-effects during the intra-and post-operative periods. Nausea and vomiting during surgery was treated with 10 mg metoclopramide, i.v. Finally, a paediatrician recorded 1-and 5-min Apgar scores of all of the neonates.
DENSITY MEASUREMENTS
The refractive index was used to measure the density of meperidine. Measurements were performed with a retractometer at room temperature without adding dextrose.
STATISTICAL ANALYSES
A reduction in the incidence of hypotension was the primary outcome; the duration of post-operative analgesia was a secondary outcome. The investigators sought to reduce the incidence of hypotension by 50% from the 50 -70% incidence reported in a study where 25 mg hyperbaric meperidine was added to 5 mg isobaric bupivacaine, intrathecally. 14 By performing a power calculation (Biostat Inc., Englewood, NJ, USA), it was determined that 19 patients were needed per group to demonstrate a significant difference among the groups, given a power of 80% (1β) and an α of 0.05.
Data were expressed as n (%) and mean ± SD. All statistical analyses were carried out using the SPSS ® statistical package, version 11.5 (SPSS Inc., Chicago, IL, USA) for Windows ® . The Kruskal-Wallis one-way analysis of variance and Mann-Whitney Utests were used to compare continuous variables and the Pearson's χ 2 -test was used to compare categorical variables between the treatment groups. The level of significance was subsequently set at α = 0.013 (after performing Bonferroni correction for the four comparisons).
Results
Eighty patients were included in the study: 20 were randomized to each of the four treatment groups. All patients completed the study successfully. Demographic data and surgical characteristics were similar in all groups ( Table 1) .
The incidence of each of the side-effects evaluated in this study is shown in Table 2 . The incidence of hypotension in the BM25 group was significantly lower than in the HB group (P < 0.001). Ephedrine requirement in the BM25 group was significantly lower than that for patients in the HB group (P < 0.001). The onset of hypotension in all treatment Intrathecal bupivacaine and meperidine for caesarean section groups occurred between 5 and 15 min (mean ± SD 10 ± 5 min) after spinal injection. Nausea (P = 0.001) and vomiting (P < 0.001) were significantly less prevalent in the BM25 group than in the HB and BM35 groups. The onset of these symptoms in all treatment groups began between 10 and 20 min (mean ± SD 15 ± 5 min) after the spinal injection. Pruritus was not noted in the HB group. Patients receiving the highest intrathecal meperidine (pethidine) dose (the BM35 group) experienced the highest incidence of pruritis, whereas those in the BM25 group experienced the lowest incidence of this side-effect (P < 0.001 for the BM25 group versus the BM35 and BM30 groups). Ten of the 20 patients in the HB group (50%) experienced intraoperative shivering, compared with none of the patients who received meperidine.
The assessment of abdominal muscle relaxation, the time required for the motor block to reach a Bromage score of 2, and the time required for the sensory block to reach the T4 dermatome were similar in all groups (Table 3 ). The mean ± SD time-to-regression Data are n (%) of patients or mean ± SD. a P < 0.001 compared with the HB group; b P = 0.001 compared with the HB and BM35 groups; c P < 0.001 compared with the HB and BM35 groups; d P < 0.001 compared with the BM35 and BM30 groups; Kruskal-Wallis one-way analysis of variance and Mann-Whitney U-tests were used to compare continuous variables and Pearson's χ 2 -test was used to compare categorical variables. HB, hyperbaric bupivacaine; BM, plain bupivacaine plus 35, 30 or 25 mg meperidine. Intrathecal bupivacaine and meperidine for caesarean section of motor block (i.e. the time required to reach a Bromage score of 0) for patients in the BM25 group was significantly lower than that for patients in all other groups (P < 0.001; Table 3 ). In addition, the number of patients with a Bromage score of 0 at 90 min was significantly different in the BM25 group compared with all other groups (P < 0.001; Fig. 1 ). The level of peak sensory block was similar in all groups (Table 3 ). The duration of analgesia was significantly shorter in the HB group than in all other groups (P < 0.001). The duration of analgesia in the BM35 group was significantly longer than in the BM30 and BM25 groups (P = 0.01), whereas no statistically significant differences were observed between the BM30 and BM25 groups with regard to duration of analgesia (Table 3) . Abdominal muscle relaxation, as assessed by the surgeon, and patient satisfaction did not differ significantly between the groups (Tables 3 and 4 ). Measurement of the refractive index showed the density of meperidine to be 1.020 g/ml, confirming that it was a hyperbaric solution.
Discussion
The present study showed that, compared with hyperbaric bupivacaine, the sequential subarachnoid administration of 5 mg plain bupivacaine and 25 mg of hyperbaric meperidine was associated with a marked decrease in the incidence of hypotension and other side-effects. In addition, the intrathecal administration of plain bupivacaine plus hyperbaric meperidine (pethidine) at all doses increased the duration of spinal analgesia compared with hyperbaric bupivacaine alone. These effects on hypotension and the incidence of side-effects were inversely proportional to the dose of Time-to-sensory block T4 (min) 6.1 ± 1.4 6.5 ± 1.5 6.9 ± 1. 8 (7 -9) 8 (7 -9) 8 (7 -9) 8 (7 -9) Apgar score 5 (min) 9 (8 -10) 9 (7 -10) 9 (7 -10) 9 (8 -10)
Data are mean ± SD, mean (range), or n. a P < 0.001 compared with all other groups; b P = 0.01 compared with the BM30 and BM25 groups; Kruskal-Wallis one-way analysis of variance and Mann-Whitney U-tests were used to compare continuous variables and Pearson's χ 2 -test was used to compare categorical variables. HB, hyperbaric bupivacaine; BM, plain bupivacaine plus 35, 30 or 25 mg meperidine; Br, Bromage scale of 0 -3 (0, no block; 1, impaired hip flexion; 2, impaired hip and knee movement; 3, impaired hip, knee and ankle movement).
TABLE 3: Characteristics of the level of sensory and motor block achieved, and assessment of muscle relaxation recorded, for patients undergoing elective caesarean sections with spinal anaesthesia, together with Apgar scores for their newborn infants Intrathecal bupivacaine and meperidine for caesarean section
intrathecal meperidine. The amount of ephedrine that was administered was significantly lower in the BM25 group compared with the HB and BM35 groups. Small doses of isobaric solutions have a limited distribution, whereas hyperbaric solutions have a diffuse distribution depending on the patient's position and can, therefore, induce serious hypotension by causing total sympathetic block. 15, 16 In obstetric patients, however, the intrathecal use of plain or hyperbaric bupivacaine alters the height of the spinal block used. 17, 18 Srivastava et al. 19 compared the effects of hyperbaric bupivacaine versus plain bupivacaine combined with fentanyl with regard to the degree of sensory and motor block, the quality of intraoperative anaesthesia, and the 
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incidence of side-effects. The study found no difference between the two groups, despite differences in the baricity of the bupivacaine, suggesting that the spread of spinal solution was not dependent on the density of the anaesthetic that was administered in patients undergoing caesarean section. 19 The blood pressure readings were, however, higher in the hyperbaric bupivacaine group. 19 Even when the dose of hyperbaric bupivacaine was not reduced, the addition of hypobaric opioids (e.g. fentanyl, sufentanil) decreased the incidence of hypotension associated with spinal anaesthesia. 19, 20 We believe that this reduction was due to a change in the density of the mixture, but further studies are needed to verify this.
Bupivacaine is considered isobaric by most practicing anaesthetists, with densities of 0.9990 g/ml at 37°C and 1.0006 g/ml at room temperature; in fact, it is slightly hypobaric at body temperature. 5 Meperidine, a phenylperidine derivative, is the opiate that most closely resembles local anaesthetics in terms of molecular weight and dissociation constant (pK a ). 21 Unlike other opioids, meperidine is hyperbaric (density 1.0083 g/ml at 37°C, 1.014 g/ml at room temperature). 5 For the present study, the refractive index was used to measure density, with the measurement performed at room temperature without adding dextrose. We found that the density of meperidine was 1.020 g/ml, making it a hyperbaric solution.
Cesur et al. 12 stated that to reduce or eliminate some of the disadvantages associated with the use of hyperbaric and isobaric spinal anaesthesia, while preserving the advantages of both, low doses (1 ml) of plain and hyperbaric bupivacaine should be administered sequentially. This regimen reduced the incidence of hypotension, when compared with the use of hyperbaric bupivacaine alone (13.9% versus 66.7%, respectively). 12 Plain bupivacaine plus hyperbaric meperidine was administered sequentially in the present study because each acts differently according to its dynamic properties. Low-dose plain bupivacaine was used to obtain dense anaesthesia surrounding the incision area, then administration of hyperbaric meperidine was used to suppress visceral pain. The present results were similar to those of Cesur et al.: 12 in both studies, the incidence of hypotension decreased in the groups in which isobaric and hyperbaric agents were administered intrathecally in a sequential manner.
In another study, Conway et al. 11 administered 0.8 mg/kg meperidine, 0.4 mg/kg meperidine plus 1.5 ml bupivacaine, or 3 ml bupivacaine alone, to patients and determined that intrathecal meperidine alone or mixed with hyperbaric bupivacaine had no intraoperative advantages over hyperbaric bupivacaine alone. In contrast to the present 11 used hyperbaric bupivacaine in combination with higher doses of other drugs. It was observed in the present study that hypotension was less common in patients who received plain bupivacaine plus meperidine than in the patients who received hyperbaric bupivacaine alone. The degree of hypotension experienced was also inversely proportional to the dose of meperidine used: hypotension was observed in 65% of the patients who received hyperbaric bupivacaine but this rate dropped to 20% when isobaric bupivacaine was combined with 25 mg of meperidine. Hypotension is the most important cause of intraoperative nausea and vomiting. 22 The administration of larger doses of intrathecal meperidine has also been associated with nausea or vomiting when meperidine is used as the sole agent for spinal anaesthesia in patients undergoing caesarean section. 8, 23, 24 Abouleish et al. 25 observed a lower incidence of intraoperative vomiting in patients who received lower doses of parenteral narcotics, despite the fact that the incidence of hypotension was the same in the study and control groups. The incidence of hypotension was correlated with the incidence of nausea and vomiting in the present study: the frequency of nausea and vomiting was the same in the HB and BM35 groups. In contrast, when the meperidine dose was lowered, the incidence of hypotension decreased and a significant reduction in the frequency of nausea and vomiting was noted. Thus, the findings of the present study indicate that an increase in the incidence of hypotension also led to an increase in the incidence of nausea and vomiting.
Conway et al. 11 did not observe bradycardia in any of the patients who received only 3 ml bupivacaine. They did, however, observe bradycardia in six patients who received 0.8 mg/kg meperidine only, and in four patients who received 1.5 mg bupivacaine plus 0.4 mg/kg meperidine, and all episodes of bradycardia were managed with atropine. 11 None of the patients in the present study developed bradycardia. This was ascribed to the fact that our patients were younger and received lower doses of meperidine than those included in the study performed by Conway et al. 11 No neurological symptoms were observed in the 24 h following surgery in any of the patients in the present study. The mean 1-and 5-min Apgar scores of the newborns in the present study were 8 and 9, respectively, and there were no significant differences observed among the treatment groups. Previous studies that have investigated the effects of intrathecal opiate use on the fetuses and neonates of mothers who received this type of anaesthesia have examined Apgar scores, umbilical cord blood acid/base status and blood gas measurements of such infants, and have found no significant side-effects associated with the use of these agents. 26 The addition of 10 µg of fentanyl to 10.5 -12.5 mg of hyperbaric bupivacaine increased the duration of analgesia in the intraoperative and early post-operative periods in a study where the duration of analgesia varied between 2.5 and 4 h. 27 In the study by Yu et al., 3 the first post-operative analgesic was required at 234 min after surgery when 0.2 ml (10 mg) of meperidine was combined with the same amount of bupivacaine. In the present study, the first post-operative analgesic requirement was observed 185 ± 20, 403 ± 43, 315 ± 29 and 295 ± 23 min after surgery in the HB, BM35, BM30, and BM25 groups, respectively. No respiratory depression was observed in any of the patients after the use of intrathecal meperidine.
The use of intrathecal and epidural opiates has been shown to result in early 
post-operative mobilization and shorter hospitalizations, especially in high-risk patients. 28 Cheun and Kim 23 concluded that meperidine was a good agent to use for spinal anaesthesia during caesarean sections because it provided rapid motor recovery and prolonged post-operative analgesia. In the present study, compared with the HB group, the duration of motor block was significantly shorter in the groups in which plain bupivacaine was supplemented with meperidine: this effect was directly proportional to the decrease in the meperidine dose. Motor block was not regressed in any patient in the HB group at 90 min whereas, at that time, the motor block was fully regressed in all patients in the BM25 group. As a result of reducing the dose of bupivacaine, the motor blocks resolved earlier in response to meperidine in a dose-dependent fashion and patients became mobilized earlier. Additionally, sensorial block was at the desired level of T4 in all groups and there were no significant between-group differences with regard to the level of sensorial block.
An incidence of pruritus of 10.7 -32% has been reported with the use of ≥ 50 mg of intrathecal meperidine. 24 Pruritus was not observed in the HB group in the present study, whereas it was experienced by 45%, 35%, and 10% of the patients in the BM35, BM30 and BM25 groups, respectively. Shivering is also an important issue during spinal and epidural anaesthesia and has been reported to occur in 50.7% of patients. 29 Chen et al. 30 reported that the administration of 10 mg of intrathecal meperidine significantly reduced the incidence of shivering, and the absence of shivering in the groups that received meperidine in the present study was consistent with these findings. One limitation of the present study was the difference in the volume of spinal anaesthetic used in each treatment group, although the difference in volume was small and unlikely to have affected the results. 15 Another limitation was that it may have been useful to compare the sequential administration of bupivacaine and meperidine with the administration of both agents in the same mixture.
In conclusion, when plain 5 mg bupivacaine and sequential 5 mg bupivacaine with different doses of meperidine were administered intrathecally for anaesthesia prior to caesarean section, better haemodynamic stability and fewer side-effects occurred with the addition of 25 mg meperidine to plain bupivacaine, without affecting the quality of anaesthesia or surgical and patient satisfaction. Further studies are necessary to assess the safety and efficacy of low-dose bupivacaine and meperidine administered intrathecally for spinal anaesthesia.
